Viemed Healthcare, Inc.
VMD- 1D
- +0.9%
Viemed Healthcare, Inc. in brief
Viemed Healthcare, Inc. is a listed company in the Medical Equipment industry, based in Lafayette, Louisiana, USA. It was founded in 2006. Its market value was $367 M on 15 October 2026, which makes it the 13,910th largest listed company in the world and the 2,733rd largest in the USA on this site. In the year to December 2025 it had sales of $270 M and a net profit of $15 M, about 6 cents of profit for every dollar of sales. Casey Hoyt is its chief executive. Its largest product and service lines by sales in 2025 were Equipment and supply sales (19%). Its shares trade under the symbol VMD (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Viemed Healthcare, Inc.
Viemed Healthcare is Provides Home Respiratory Service company to patients struggling with various respiratory diseases including chronic obstructive pulmonary disease (COPD) and various neuromuscular diseases. The company annual revenue is 131.3 million USD, annual operating income is 26.7 million USD and annual net income is 31.5 million USD. The headquarters is in USA.
Viemed Healthcare, Inc. timeline
- 2006
- 🏁· approximateFounded
- 2018
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2020
- 💰Record net income of $32 millionFY2020, the highest profit of the 8 years on record.
- 2025
- 💰Record revenue of $270 millionFY2025, the highest of the 8 years on record.
Events of Viemed Healthcare, Inc. from the company record, SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #3,089 (Jan 2020) · #2,928 (Jan 2021) · #3,763 (Jan 2022) · #3,306 (Dec 2022) · #3,040 (Jul 2023) · #2,936 (Jan 2024) · #1,450 (Mar 2026) · #2,751 (Aug 2026) · #2,732 (Oct 2026) · #2,737 (Oct 2026)
Key ratios
- P/E ratio (TTM)
- 23.5×
- Price / sales (TTM)
- 1.2×
- Price / book
- 2.6×
- Free cash flow yield
- 3.3%
- Net margin (TTM)
- 5.0%
- Operating margin
- 8.5%
- Return on equity
- 11.0%
- Liabilities / assets
- 27.9%
- Net debt
- $-2M
- Revenue growth
- +20.5%
- R&D / revenue
- 1.1%
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $270M | +20.5% | $23M | $15M | 5.5% |
| Dec 2024 | $224M | +22.5% | $18M | $11M | 5.0% |
| Dec 2023 | $183M | +31.8% | $14M | $10M | 5.6% |
| Dec 2022 | $139M | +18.6% | $8M | $6M | 4.5% |
| Dec 2021 | $117M | -10.9% | $12M | $9M | 7.8% |
| Dec 2020 | $131M | +63.6% | $27M | $32M | 24.0% |
| Dec 2019 | $80M | +24.5% | $9M | $9M | 10.6% |
| Dec 2018 | $64M | — | $10M | $10M | 14.8% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $52M | $40M | $12M | $0.37 | — |
| Dec 2024 | $39M | $38M | $1M | $0.28 | — |
| Dec 2023 | $45M | $26M | $19M | $0.25 | — |
| Dec 2022 | $28M | $23M | $5M | $0.16 | — |
| Dec 2021 | $22M | $20M | $3M | $0.22 | — |
| Dec 2020 | $35M | $13M | $22M | $0.78 | — |
| Dec 2019 | $19M | $13M | $6M | $0.21 | — |
| Dec 2018 | $22M | $6M | $16M | $0.24 | — |
Quarterly results
Latest quarter to Sep 2026: revenue $81M (+12.2% on a year earlier), net income $5M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.
SEC filings
- Nov 4, 202610-QQuarterly report · period to Sep 2026
- Nov 4, 20268-KCurrent reportResults of operations · Regulation FD disclosure
- Aug 20, 20268-KCurrent reportRegulation FD disclosure
- Aug 3, 202610-QQuarterly report · period to Jun 2026
- Aug 3, 20268-KCurrent reportResults of operations
- Jun 4, 20268-KCurrent reportDirectors or officers changed · Shareholder vote
- Jun 2, 20268-KCurrent reportRegulation FD disclosure
- May 5, 202610-QQuarterly report · period to Mar 2026
- May 5, 20268-KCurrent reportResults of operations
- Apr 22, 2026DEF 14AProxy statement
- Mar 16, 20268-KCurrent reportRegulation FD disclosure
- Mar 4, 202610-KAnnual report · period to Dec 2025
Official filings of Viemed Healthcare, Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $270 M
- Operating income
- $23 M
- Net income
- $15 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $199 M
- Total liabilities
- $56 M
- Total equity
- $142 M
As of December-2025
Top 100 institutional investors in Viemed Healthcare, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 4,942,634 | +154,327 (+3.22%) | 13.04% | $45 M | Nov 13, 2026 |
| 2 | Forager Capital Management, LLC | 1,773,177 | -368,007 (-17.19%) | 4.68% | $16 M | Nov 16, 2026 |
| 3 | Vanguard Capital Management LLC | 1,321,396 | -280 (-0.02%) | 3.49% | $12 M | Nov 13, 2026 |
| 4 | Ameriprise Financial Inc | 1,300,898 | +294,703 (+29.29%) | 3.43% | $12 M | Nov 16, 2026 |
| 5 | Geode Capital Management, LLC | 1,171,828 | +198,084 (+20.34%) | 3.09% | $11 M | Nov 6, 2026 |
| 6 | Arrowstreet Capital, Limited Partnership | 1,043,664 | +257,395 (+32.74%) | 2.75% | $9 M | Nov 13, 2026 |
| 7 | State Street Corp | 757,224 | -4,873 (-0.64%) | 2.00% | $7 M | Nov 12, 2026 |
| 8 | Nantahala Capital Management, LLC | 714,674 | -550,216 (-43.50%) | 1.89% | $7 M | Nov 13, 2026 |
| 9 | Martin & Co Inc /TN/ | 701,680 | +360,909 (+105.91%) | 1.85% | $6 M | Nov 12, 2026 |
| 10 | Panagora Asset Management Inc | 597,497 | +58,872 (+10.93%) | 1.58% | $5 M | Nov 12, 2026 |
| 11 | Punch & Associates Investment Management, Inc. | 583,163 | +49,697 (+9.32%) | 1.54% | $5 M | Nov 16, 2026 |
| 12 | Two Sigma Investments, LP | 579,608 | +140,757 (+32.07%) | 1.53% | $5 M | Nov 16, 2026 |
| 13 | Goldman Sachs Group Inc | 578,962 | -643,572 (-52.64%) | 1.53% | $5 M | Nov 16, 2026 |
| 14 | First Eagle Investment Management, LLC | 533,157 | -537,157 (-50.19%) | 1.41% | $5 M | Nov 10, 2026 |
| 15 | Creative Planning | 486,304 | +125,948 (+34.95%) | 1.28% | $4 M | Nov 2, 2026 |
| 16 | Acadian Asset Management LLC | 475,237 | +76,651 (+19.23%) | 1.25% | $4 M | Nov 9, 2026 |
| 17 | Renaissance Technologies LLC | 465,957 | +40,057 (+9.41%) | 1.23% | $4 M | Nov 12, 2026 |
| 18 | Algert Global LLC | 465,624 | New | 1.23% | $4 M | Nov 17, 2026 |
| 19 | Vanguard Portfolio Management LLC | 423,642 | +142,309 (+50.58%) | 1.12% | $4 M | Nov 13, 2026 |
| 20 | Qube Research & Technologies Ltd | 407,271 | New | 1.07% | $4 M | Nov 13, 2026 |
| 21 | AQR Capital Management LLC | 393,202 | +187,722 (+91.36%) | 1.04% | $4 M | Nov 16, 2026 |
| 22 | Raffles Associates LP | 392,761 | -414,621 (-51.35%) | 1.04% | $4 M | Nov 16, 2026 |
| 23 | Bard Associates Inc | 338,961 | -711 (-0.21%) | 0.89% | $3 M | Nov 13, 2026 |
| 24 | Penbrook Management LLC | 275,948 | -1,230 (-0.44%) | 0.73% | $3 M | Oct 16, 2026 |
| 25 | Northern Trust Corp | 274,697 | +3,334 (+1.23%) | 0.72% | $2 M | Nov 16, 2026 |
Show all 100: investors 26 to 100
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 26 | Millennium Management LLC | 272,119 | +220,170 (+423.82%) | 0.72% | $2 M | Nov 16, 2026 |
| 27 | Tocqueville Asset Management L.P. | 272,100 | -70,000 (-20.46%) | 0.72% | $2 M | Nov 13, 2026 |
| 28 | Morgan Stanley | 269,844 | -30,566 (-10.17%) | 0.71% | $2 M | Nov 13, 2026 |
| 29 | Lazard Asset Management LLC | 253,211 | -9,275 (-3.53%) | 0.67% | $2 M | Nov 16, 2026 |
| 30 | Vanguard Fiduciary Trust Co | 242,773 | +5,983 (+2.53%) | 0.64% | $2 M | Nov 13, 2026 |
| 31 | Expect Equity LLC | 221,878 | +9,157 (+4.30%) | 0.59% | $2 M | Nov 16, 2026 |
| 32 | State Board Of Administration Of Florida Retirement System | 210,001 | New | 0.55% | $2 M | Nov 13, 2026 |
| 33 | Rice Hall James & Associates, LLC | 196,263 | -12,803 (-6.12%) | 0.52% | $2 M | Nov 16, 2026 |
| 34 | Dimensional Fund Advisors LP | 189,931 | 0 (0.00%) | 0.50% | $2 M | Nov 4, 2026 |
| 35 | UBS Group AG | 170,449 | +91,736 (+116.54%) | 0.45% | $2 M | Nov 10, 2026 |
| 36 | Y-Intercept (Hong Kong) Ltd | 170,411 | +142,297 (+506.14%) | 0.45% | $2 M | Oct 16, 2026 |
| 37 | Trexquant Investment LP | 164,669 | +75,389 (+84.44%) | 0.43% | $1 M | Nov 16, 2026 |
| 38 | Citadel Advisors LLC | 158,397 | -75,918 (-32.40%) | 0.42% | $1 M | Nov 16, 2026 |
| 39 | Gsa Capital Partners LLP | 143,470 | +15,879 (+12.45%) | 0.38% | $1 M | Nov 16, 2026 |
| 40 | Man Group plc | 139,830 | +45,742 (+48.62%) | 0.37% | $1 M | Nov 16, 2026 |
| 41 | Point72 Asset Management, L.P. | 134,517 | -21,325 (-13.68%) | 0.35% | $1 M | Nov 16, 2026 |
| 42 | Quantinno Capital Management LP | 134,180 | +16,470 (+13.99%) | 0.35% | $1 M | Nov 13, 2026 |
| 43 | Bank of New York Mellon Corp | 105,089 | +15,091 (+16.77%) | 0.28% | $1 M | Nov 5, 2026 |
| 44 | North Star Investment Management Corp. | 105,000 | +5,000 (+5.00%) | 0.28% | $1 M | Oct 27, 2026 |
| 45 | Strs Ohio | 103,800 | +41,300 (+66.08%) | 0.27% | $1 M | Oct 30, 2026 |
| 46 | Nuveen, LLC | 101,668 | -14,823 (-12.72%) | 0.27% | $1 M | Nov 10, 2026 |
| 47 | Charles Schwab Investment Management Inc | 99,904 | +217 (+0.22%) | 0.26% | $1 M | Nov 16, 2026 |
| 48 | Magnetar Financial LLC | 99,709 | +58,397 (+141.36%) | 0.26% | $1 M | Nov 13, 2026 |
| 49 | Gabelli Funds LLC | 92,400 | 0 (0.00%) | 0.24% | $1 M | Nov 12, 2026 |
| 50 | Barclays PLC | 90,968 | +28,681 (+46.05%) | 0.24% | $1 M | Nov 6, 2026 |
| 51 | Salem Investment Counselors Inc | 75,982 | +18,000 (+31.04%) | 0.20% | $1 M | Oct 13, 2026 |
| 52 | Round Rock Advisors LLC | 69,292 | 0 (0.00%) | 0.18% | $1 M | Nov 12, 2026 |
| 53 | Mangrove Partners Im, LLC | 68,561 | -7,618 (-10.00%) | 0.18% | $1 M | Nov 16, 2026 |
| 54 | Creative Planning Institutional Advisors, LLC | 68,549 | +41,922 (+157.44%) | 0.18% | $1 M | Nov 16, 2026 |
| 55 | Campbell & CO Investment Adviser LLC | 67,150 | +6,300 (+10.35%) | 0.18% | $1 M | Nov 13, 2026 |
| 56 | RBF Capital, LLC | 65,972 | 0 (0.00%) | 0.17% | $1 M | Nov 13, 2026 |
| 57 | Bank Of America Corp /de/ | 56,875 | -101,887 (-64.18%) | 0.15% | $1 M | Nov 16, 2026 |
| 58 | Russell Investments Group, Ltd. | 55,011 | +29,981 (+119.78%) | 0.15% | $1 M | Nov 6, 2026 |
| 59 | Invesco Ltd. | 53,587 | +10,989 (+25.80%) | 0.14% | $0 M | Nov 12, 2026 |
| 60 | Verdad Advisers, LP | 52,879 | 0 (0.00%) | 0.14% | $0 M | Nov 16, 2026 |
| 61 | Integrated Quantitative Investments LLC | 51,206 | -13,824 (-21.26%) | 0.14% | $0 M | Nov 13, 2026 |
| 62 | HSBC Holdings PLC | 46,443 | +8,151 (+21.29%) | 0.12% | $0 M | Nov 16, 2026 |
| 63 | Numerai GP LLC | 46,431 | -28,625 (-38.14%) | 0.12% | $0 M | Nov 13, 2026 |
| 64 | Martingale Asset Management L P | 44,147 | +1,726 (+4.07%) | 0.12% | $0 M | Nov 12, 2026 |
| 65 | State of Wyoming | 40,335 | New | 0.11% | $0 M | Oct 28, 2026 |
| 66 | Rhumbline Advisers | 39,645 | -911 (-2.25%) | 0.10% | $0 M | Nov 10, 2026 |
| 67 | Hillsdale Investment Management Inc. | 39,000 | -186,109 (-82.68%) | 0.10% | $0 M | Nov 12, 2026 |
| 68 | BNP Paribas Financial Markets | 37,009 | -97,585 (-72.50%) | 0.10% | $0 M | Nov 12, 2026 |
| 69 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 36,316 | +32,011 (+743.58%) | 0.10% | $0 M | Nov 16, 2026 |
| 70 | Summit Global Investments | 36,109 | 0 (0.00%) | 0.10% | $0 M | Oct 28, 2026 |
| 71 | Engineers Gate Manager LP | 35,531 | -1,136 (-3.10%) | 0.09% | $0 M | Nov 16, 2026 |
| 72 | Public Employees Retirement System Of Ohio | 32,528 | New | 0.09% | $0 M | Nov 16, 2026 |
| 73 | Aristides Capital LLC | 30,494 | +13,481 (+79.24%) | 0.08% | $0 M | Nov 16, 2026 |
| 74 | Deutsche Bank AG\ | 29,744 | -4,138 (-12.21%) | 0.08% | $0 M | Nov 6, 2026 |
| 75 | Rothschild Wealth LLC | 29,716 | -832 (-2.72%) | 0.08% | $0 M | Nov 12, 2026 |
| 76 | Walleye Capital LLC | 29,365 | -154,544 (-84.03%) | 0.08% | $0 M | Nov 13, 2026 |
| 77 | Price T Rowe Associates Inc /MD/ | 27,976 | 0 (0.00%) | 0.07% | $0 M | Nov 16, 2026 |
| 78 | Seizert Capital Partners, LLC | 27,947 | -1,899 (-6.36%) | 0.07% | $0 M | Oct 30, 2026 |
| 79 | Mercer Global Advisors Inc /adv | 27,362 | +4,770 (+21.11%) | 0.07% | $0 M | Nov 16, 2026 |
| 80 | CenterBook Partners LP | 27,330 | New | 0.07% | $0 M | Nov 2, 2026 |
| 81 | Semanteon Capital Management, LP | 26,796 | +6,925 (+34.85%) | 0.07% | $0 M | Nov 9, 2026 |
| 82 | WINTON GROUP Ltd | 26,555 | New | 0.07% | $0 M | Nov 12, 2026 |
| 83 | Squarepoint Ops LLC | 26,022 | +2,415 (+10.23%) | 0.07% | $0 M | Nov 9, 2026 |
| 84 | Bridgeway Capital Management, LLC | 25,391 | 0 (0.00%) | 0.07% | $0 M | Nov 16, 2026 |
| 85 | SEI Investments Co | 25,207 | -48,358 (-65.74%) | 0.07% | $0 M | Nov 10, 2026 |
| 86 | LPL Financial LLC | 23,886 | -106 (-0.44%) | 0.06% | $0 M | Nov 6, 2026 |
| 87 | Vestcor Inc | 23,563 | 0 (0.00%) | 0.06% | $0 M | Nov 12, 2026 |
| 88 | BCM Advisors, LLC | 23,520 | 0 (0.00%) | 0.06% | $0 M | Nov 3, 2026 |
| 89 | MBB Public Markets I LLC | 23,384 | 0 (0.00%) | 0.06% | $0 M | Nov 16, 2026 |
| 90 | Blair William & Co/il | 23,129 | -374 (-1.59%) | 0.06% | $0 M | Nov 10, 2026 |
| 91 | StoneX Group Inc. | 18,494 | New | 0.05% | $0 M | Nov 3, 2026 |
| 92 | MetLife Investment Management, LLC | 18,170 | 0 (0.00%) | 0.05% | $0 M | Nov 16, 2026 |
| 93 | Spark Investment Management LLC | 18,100 | New | 0.05% | $0 M | Nov 13, 2026 |
| 94 | Jpmorgan Chase & Co | 18,013 | -93,149 (-83.80%) | 0.05% | $0 M | Nov 12, 2026 |
| 95 | Susquehanna International Group, LLP | 17,591 | -57,838 (-76.68%) | 0.05% | $0 M | Nov 16, 2026 |
| 96 | Osaic Holdings, Inc. | 17,200 | -5,590 (-24.53%) | 0.05% | $0 M | Nov 12, 2026 |
| 97 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 16,437 | +815 (+5.22%) | 0.04% | $0 M | Nov 16, 2026 |
| 98 | Ulland Investment Advisors, LLC | 15,870 | -12,675 (-44.40%) | 0.04% | $0 M | Oct 13, 2026 |
| 99 | Jump Financial, LLC | 15,659 | -10,715 (-40.63%) | 0.04% | $0 M | Nov 13, 2026 |
| 100 | Diversified Trust Co | 15,597 | +3,980 (+34.26%) | 0.04% | $0 M | Nov 6, 2026 |
Mutual funds holding Viemed Healthcare, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc. | 912,713 | $10 M | 3.0% | <0.01% | +0.3% | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors | 870,045 | $10 M | 2.9% | 0.01% | +7.3% | Jun 30, 2026 |
| 🇺🇸 Columbia Small Cap Value Discovery FundColumbia Management Investment Advisers, LLC | 566,630 | $7 M | 1.9% | 0.26% | +6.5% | Jul 31, 2026 |
| 🇺🇸 First Eagle Small Cap Opportunity FundFirst Eagle Investment Management, LLC | 467,300 | $5 M | 1.6% | 0.19% | +1.1% | Jul 31, 2026 |
| 🇺🇸 BlackRock Advantage Small Cap Core FundBlackRock Advisors, LLC | 485,288 | $5 M | 1.6% | 0.09% | −1.3% | May 29, 2026 |
| 🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC | 372,227 | $4 M | 1.2% | 0.01% | +13% | Jul 31, 2026 |
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 373,459 | $4 M | 1.2% | <0.01% | +2.2% | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors | 319,961 | $4 M | 1.1% | 0.02% | +18% | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc. | 171,949 | $2 M | 0.57% | <0.01% | +1.2% | May 31, 2026 |
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 170,736 | $2 M | 0.57% | <0.01% | −1.5% | May 31, 2026 |
| 🇺🇸 BlackRock Advantage Small Cap Growth FundBlackRock Funds | 124,615 | $1 M | 0.42% | 0.17% | −27% | Jun 30, 2026 |
| 🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors | 114,129 | $1 M | 0.38% | 0.09% | +35% | Jun 30, 2026 |
| 🇺🇸 First Trust Dow Jones Select MicroCap Index FundFirst Trust Advisors L.P. | 110,694 | $1 M | 0.37% | 0.48% | +5.2% | Jun 30, 2026 |
| 🇺🇸 Fidelity SAI Small-Mid Cap Momentum Index FundFidelity Management & Research Company LLC | 101,049 | $1 M | 0.34% | 0.03% | new | Jul 31, 2026 |
| 🇺🇸 Columbia Variable Portfolio - Small Cap Value Discovery FundColumbia Management Investment Advisers, LLC | 102,520 | $1 M | 0.34% | 0.26% | −3.3% | Jun 30, 2026 |
| 🇺🇸 Goldman Sachs Small Cap Equity Insights FundGoldman Sachs Asset Management, L.P. | 97,561 | $1 M | 0.33% | 0.11% | −52% | Jul 31, 2026 |
| 🇺🇸 The Canadian Small Company SeriesDimensional Fund Advisors LP | 93,487 | $1 M | 0.31% | 0.05% | no change | Jul 31, 2026 |
| 🇺🇸 North Star Micro Cap FundNorth Star Investment Management Corp. | 100,000 | $1 M | 0.33% | 0.53% | no change | May 31, 2026 |
| 🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc. | 83,102 | $1 M | 0.28% | 0.01% | +11% | Jul 31, 2026 |
| 🇺🇸 Gabelli Healthcare & WellnessRx TrustGabelli Funds, LLC | 85,000 | $1 M | 0.28% | 0.63% | no change | Jun 30, 2026 |
| 🇺🇸 Diversified Equity Alpha Master PortfolioBlackRock Fund Advisors | 65,414 | $1 M | 0.22% | 0.03% | −24% | Jun 30, 2026 |
| 🇺🇸 NVIT GS Small Cap Equity Insights FundNATIONWIDE FUND ADVISORS | 64,634 | $1 M | 0.22% | 0.34% | −21% | Jun 30, 2026 |
| 🇺🇸 Goldman Sachs Small Cap Growth Insights FundGoldman Sachs Asset Management, L.P. | 57,971 | $1 M | 0.19% | 0.21% | −23% | Jul 31, 2026 |
| 🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC | 59,015 | $1 M | 0.20% | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 63,614 | $1 M | 0.21% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Goldman Sachs Variable Insurance Trust Small Cap Equity Insights FundGoldman Sachs Asset Management, L.P. | 54,636 | $1 M | 0.18% | 0.27% | −17% | Jun 30, 2026 |
| 🇺🇸 BlackRock Advantage SMID Cap Fund, Inc.BlackRock Advisors, LLC | 53,409 | $1 M | 0.18% | 0.06% | no change | Jun 30, 2026 |
| 🇺🇸 Small Company Growth PortfolioThe Vanguard Group, Inc. | 45,874 | $1 M | 0.15% | 0.03% | no change | Jun 30, 2026 |
| 🇺🇸 Nuveen Equity Index FundTeachers Advisors, LLC | 44,083 | $1 M | 0.15% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Goldman Sachs ActiveBeta U.S. Small Cap Equity ETFGoldman Sachs Asset Management, L.P. | 52,165 | $1 M | 0.17% | 0.05% | +1.3% | May 31, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 50,380 | $0 M | 0.17% | <0.01% | +4.5% | May 31, 2026 |
| 🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC | 41,144 | $0 M | 0.14% | 0.01% | no change | Jul 31, 2026 |
| 🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC | 39,482 | $0 M | 0.13% | 0.01% | +19% | Jun 30, 2026 |
| 🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P. | 33,415 | $0 M | 0.11% | <0.01% | +4.5% | Jun 30, 2026 |
| 🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC | 31,923 | $0 M | 0.11% | 0.02% | +25% | Jun 30, 2026 |
| 🇺🇸 AVIP BlackRock Advantage Small Cap Growth PortfolioCONSTELLATION INVESTMENTS INC | 31,694 | $0 M | 0.11% | 0.26% | −22% | Jun 30, 2026 |
| 🇺🇸 SGI Small Cap Core FundRBB Fund, Inc. | 36,109 | $0 M | 0.12% | 0.27% | +25% | May 31, 2026 |
| 🇺🇸 Nationwide Bailard Small Cap Value FundNATIONWIDE FUND ADVISORS | 28,100 | $0 M | 0.09% | 0.25% | new | Jul 31, 2026 |
| 🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc. | 31,155 | $0 M | 0.10% | 0.02% | +0.7% | May 31, 2026 |
| 🇺🇸 State Street SPDR US Small Cap Low Volatility Index ETFSSGA Funds Management, Inc. | 24,387 | $0 M | 0.08% | 0.11% | new | Jun 30, 2026 |
| 🇺🇸 International Vector Equity PortfolioDimensional Fund Advisors LP | 23,412 | $0 M | 0.08% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation | 22,600 | $0 M | 0.08% | 0.01% | −7.8% | Jun 30, 2026 |
| 🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC | 22,060 | $0 M | 0.07% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC | 24,506 | $0 M | 0.08% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC | 17,967 | $0 M | 0.06% | <0.01% | +5.9% | Jul 31, 2026 |
| 🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc. | 17,649 | $0 M | 0.06% | 0.01% | +24% | Jun 30, 2026 |
| 🇺🇸 Strategic Advisers U.S. Total Stock FundStrategic Advisers LLC | 19,686 | $0 M | 0.07% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC | 16,188 | $0 M | 0.05% | 0.01% | +11% | Jul 31, 2026 |
| 🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc. | 16,000 | $0 M | 0.05% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc. | 14,170 | $0 M | 0.05% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc. | 14,040 | $0 M | 0.05% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 BlackRock Advantage SMID Cap V.I. FundBlackRock Advisors, LLC | 13,349 | $0 M | 0.04% | 0.09% | −27% | Jun 30, 2026 |
| 🇺🇸 Invesco RAFI US 1500 Small-Mid ETFInvesco Capital Management LLC | 12,860 | $0 M | 0.04% | <0.01% | +127% | Jul 31, 2026 |
| 🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC | 12,516 | $0 M | 0.04% | <0.01% | +8.4% | Jul 31, 2026 |
| 🇺🇸 iShares Russell 3000 ETFBlackRock Fund Advisors | 11,706 | $0 M | 0.04% | <0.01% | −0.8% | Jun 30, 2026 |
| 🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc. | 11,600 | $0 M | 0.04% | <0.01% | −12% | Jun 30, 2026 |
| 🇺🇸 AQR Small Cap Multi-Style FundAQR CAPITAL MANAGEMENT, LLC | 11,599 | $0 M | 0.04% | 0.03% | +89% | Jun 30, 2026 |
| 🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company | 12,800 | $0 M | 0.04% | <0.01% | +1.7% | May 31, 2026 |
| 🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC | 10,554 | $0 M | 0.04% | 0.01% | +30% | Jun 30, 2026 |
| 🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC | 10,345 | $0 M | 0.03% | 0.01% | −9.3% | Jun 30, 2026 |
| 🇺🇸 Dimensional International Core Equity 2 ETFDimensional Fund Advisors LP | 9,492 | $0 M | 0.03% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 9,600 | $0 M | 0.03% | <0.01% | +39% | Jun 30, 2026 |
| 🇺🇸 International Small Cap Growth PortfolioDimensional Fund Advisors LP | 8,932 | $0 M | 0.03% | 0.03% | no change | Jul 31, 2026 |
| 🇺🇸 VIP Disciplined Small Cap PortfolioFidelity Management & Research Company LLC | 9,000 | $0 M | 0.03% | 0.02% | no change | Jun 30, 2026 |
| 🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION | 9,000 | $0 M | 0.03% | <0.01% | +800% | May 31, 2026 |
| 🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC | 7,750 | $0 M | 0.03% | <0.01% | −0.5% | Jun 30, 2026 |
| 🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC | 7,749 | $0 M | 0.03% | 0.01% | +19% | Jun 30, 2026 |
| 🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS | 7,738 | $0 M | 0.03% | 0.01% | +19% | Jun 30, 2026 |
| 🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC | 7,613 | $0 M | 0.03% | 0.04% | +27% | Jun 30, 2026 |
| 🇺🇸 Gabelli Global Small & Mid Cap Value TrustGabelli Funds, LLC | 7,400 | $0 M | 0.02% | 0.06% | no change | Jun 30, 2026 |
| 🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC | 6,960 | $0 M | 0.02% | <0.01% | +63% | Jun 30, 2026 |
| 🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP | 6,272 | $0 M | 0.02% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC | 6,242 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Dimensional International Small Cap ETFDimensional Fund Advisors LP | 5,448 | $0 M | 0.02% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc. | 5,396 | $0 M | 0.02% | 0.01% | +16% | Jun 30, 2026 |
| 🇺🇸 Brighthouse/Dimensional International Small Company PortfolioBrighthouse Investment Advisers, LLC | 5,284 | $0 M | 0.02% | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 5,281 | $0 M | 0.02% | 0.01% | +23% | Jun 30, 2026 |
| 🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc. | 5,138 | $0 M | 0.02% | 0.01% | +21% | Jun 30, 2026 |
| 🇺🇸 Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC | 5,024 | $0 M | 0.02% | 0.01% | +0.6% | Jul 31, 2026 |
| 🇺🇸 Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC | 5,103 | $0 M | 0.02% | 0.01% | +18% | Jun 30, 2026 |
| 🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC | 4,857 | $0 M | 0.02% | 0.01% | +31% | Jun 30, 2026 |
| 🇺🇸 iShares Total U.S. Stock Market Index FundBlackRock Advisors, LLC | 4,262 | $0 M | 0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC | 4,178 | $0 M | 0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Dimensional VA International Small PortfolioDimensional Fund Advisors LP | 4,100 | $0 M | 0.01% | 0.01% | no change | Jul 31, 2026 |
| 🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC | 3,879 | $0 M | 0.01% | 0.01% | no change | Jul 31, 2026 |
| 🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC | 3,210 | $0 M | 0.01% | 0.02% | +44% | Jun 30, 2026 |
| 🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS | 3,139 | $0 M | 0.01% | 0.01% | +32% | Jul 31, 2026 |
| 🇺🇸 Nationwide Fundamental All Cap Equity PortfolioNATIONWIDE FUND ADVISORS | 3,114 | $0 M | 0.01% | <0.01% | +109% | Jul 31, 2026 |
| 🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC | 2,938 | $0 M | <0.01% | <0.01% | +30% | Jul 31, 2026 |
| 🇺🇸 VIP Extended Market Index PortfolioFidelity Management & Research Company LLC | 2,983 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management | 2,819 | $0 M | <0.01% | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Invesco Russell 2000 Dynamic Multifactor ETFInvesco Capital Management LLC | 3,094 | $0 M | 0.01% | 0.01% | −53% | May 31, 2026 |
| 🇺🇸 Voya VACS Index Series SC PortfolioVoya Investments, LLC | 2,606 | $0 M | <0.01% | 0.01% | +11% | Jun 30, 2026 |
| 🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC | 2,601 | $0 M | <0.01% | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 International Small Company TrustJohn Hancock Variable Trust Advisers LLC | 2,600 | $0 M | <0.01% | 0.03% | no change | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc. | 2,259 | $0 M | <0.01% | <0.01% | +6.8% | May 31, 2026 |
| 🇺🇸 Strategic Equity Allocation TrustJohn Hancock Variable Trust Advisers LLC | 1,840 | $0 M | <0.01% | <0.01% | −25% | Jun 30, 2026 |
| 🇺🇸 Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Advisors LLC | 1,600 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Avantis International Equity ETFAmerican Century ETF Trust | 1,648 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC | 1,576 | $0 M | <0.01% | <0.01% | +6.5% | May 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 100 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at Viemed Healthcare, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Timothy SmokoffDirector | Option exercise | +15,029 | — | — | 90,547 | Form 4 |
| filed | Sabrina HeltzDirector | Option exercise | +15,029 | — | — | 82,520 | Form 4 |
| filed | Randy E. DobbsDirector | Option exercise | +16,763 | — | — | 142,253 | Form 4 |
| filed | Nitin KaushalDirector | Option exercise | +18,786 | — | — | 161,361 | Form 4 |
| filed | Sabrina HeltzDirector | Option exercise | +3,757 | — | — | 86,277 | Form 4 |
| filed | Timothy SmokoffDirector | Option exercise | +3,757 | — | — | 94,304 | Form 4 |
| filed | Randy E. DobbsDirector | Option exercise | +4,191 | — | — | 146,444 | Form 4 |
| filed | Sabrina HeltzDirector | Disposal to the company | -3,757 | $8.940 | $34 K | 82,520 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: Viemed Healthcare, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
| Buybacks, quarter | Fiscal | Spent |
|---|---|---|
| Q3 2026 | Q3 2026 | $1M |
| Q2 2026 | Q2 2026 | $5.3M |
| Q1 2026 | Q1 2026 | $1.4M |
| Q4 2025 | Q4 2025 | $0M |
| Q3 2025 | Q3 2025 | $11.6M |
| Q2 2025 | Q2 2025 | $1.7M |
| Q1 2025 | Q1 2026 | $0M |
| Q4 2024 | Q4 2024 | $0M |
| Q3 2024 | Q3 2025 | $0M |
| Q4 2023 | Q4 2023 | $0M |
| Q3 2023 | Q3 2023 | $0M |
| Q2 2023 | Q2 2023 | $0M |
| Q1 2023 | Q1 2023 | $0M |
| Q4 2022 | Q4 2022 | $0.7M |
| Q3 2022 | Q3 2022 | $1.9M |
| Q2 2022 | Q2 2022 | $5.1M |
Fails to deliver
- : 544 shares at $9.69
- : 370 shares at $9.60
- : 612 shares at $9.13
- : 711 shares at $9.23
- : 102 shares at $8.85
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Viemed Healthcare, Inc. scorecard#
Passes 21 of the 26 checks that could be worked out: strongest in financial health (5 of 5), weakest in valuation (4 of 6). Fiscal year 2025; market cap of Oct 15, 2026.
Valuation4 of 6
- ✓P/E below its peers' median23.5×P/E 23.5× against Healthcare's median of 30.0×.
- ✓Price to book below its peers' median2.6×Price to book 2.6× against Healthcare's median of 3.1×.
- ✓Price to sales below its peers' median1.2×Price to sales 1.2× against Healthcare's median of 3.8×.
- ✗Free cash flow yield above 5%3.2%Free cash flow is 3.2% of the market value.
- ✗Earnings yield above the 10-year Treasury yield4.3%Earnings yield 4.3% against the 10-year Treasury's 5.15% on 2026-11-13.
- ✓The price assumes slower growth than the last three years'15.2%The price assumes 15.2% a year for ten years; revenue grew 24.9% a year over the last three.
Growth5 of 6
- ✓Revenue grew in the newest year20.5%Revenue up 20.5% in fiscal 2025.
- ✓Revenue up more than 5% a year over three years24.9%24.9% a year over the three years to fiscal 2025.
- ✓Faster growth over three years than its peers' median24.9%24.9% a year against Medical Equipment's median of 24.7% (5 companies).
- ✓Earnings per share grew in the newest year0.37 vs 0.28Diluted EPS 0.37 in fiscal 2025 against 0.28 the year before (report's currency).
- ✗Net income higher than five years earlier$15 M$15 M in fiscal 2025 against $32 M in 2020.
- ✓Revenue rose in at least four of the last five years4 of 5Revenue rose in 4 of the five years to fiscal 2025.
Profitability5 of 6
- ✓Profitable in the newest year$15 MNet income $15 M in fiscal 2025.
- ✓Profitable in each of the last five years5 of 5Profitable in 5 of the five years to fiscal 2025.
- ✓Operating margin above its peers' median8.5%8.5% against Medical Equipment's median of -38.5% (8 companies).
- ✗Return on equity above 15%10.9%10.9% in fiscal 2025.
- ✓Return on invested capital above 10%12.6%12.6% in fiscal 2025.
- ✓Operating margin wider than three years earlier8.5%8.5% in fiscal 2025 against 5.9% in 2022.
Financial health5 of 5
- ✓Short-term assets cover short-term liabilities1.2×Current ratio 1.18 at the end of fiscal 2025.
- ✓Debt below equity0.1×Debt to equity 0.08 at the end of fiscal 2025.
- ✓Net debt below three years of EBITDANet cashMore cash than debt: net cash of $2 M at the end of fiscal 2025.
- –Operating income covers interest five timesInterest expense is not on file.
- ✓Cash from operations positive in each of the last three years3 of 3Positive in 3 of the three years to fiscal 2025.
- ✓Altman Z-score outside the distress zone6.47Z-score 6.47 (safe zone) for fiscal 2025.
Shareholder returns2 of 3
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✓Share count up no more than 2% in a year0.1%Diluted shares up 0.1% in fiscal 2025.
- ✓Dividends and buybacks above 3% of the market value3.6%Dividends and buybacks were 3.6% of the market value.
- ✗Free cash flow covers dividends and buybacks$12 MFree cash flow $12 M against $13 M paid out in fiscal 2025.
Worked out from the statements as filed (sec), the medians of Medical Equipment, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from Viemed Healthcare, Inc.'s statements, beside the median of Medical Equipment.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | 8.5% | -38.5% | |
| Net margin | 5.5% | -44.9% | |
| Return on equity | 10.9% | -94.5% | |
| Revenue growth, 3 years a year | 24.9% | 24.7% | |
| Revenue growth | 20.5% | 15.6% | |
| Debt to equity | 0.08× | — |
6of 9on the Piotroski tests of financial strength
- Revenue has grown 4 years in a row.
- Free cash flow has been positive 8 years in a row.
- More cash than debt: net cash of $2 million.
Viemed Healthcare, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 | FY 2019to Dec 31, 2019 | FY 2018to Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 270+20.5%100% | 224+22.5%100% | 183+31.8%100% | 139+18.6%100% | 117−10.8%100% | 131+63.6%100% | 80+24.5%100% | 64—100% | |
| Cost of revenue | 115+26.1%42.5% | 91+29.7%40.6% | 70+29.7%38.4% | 54+24.1%39.0% | 44−14.7%37.3% | 51+111%39.0% | 24+45.3%30.2% | 17—25.9% | |
| Gross profit | 155+16.7%57.5% | 133+18.1%59.4% | 113+33.2%61.6% | 85+15.4%61.0% | 73−8.4%62.7% | 80+43.0%61.0% | 56+17.2%69.8% | 48—74.1% | |
| Research and development | 3.0−1.7%1.1% | 3.1+10.3%1.4% | 2.8+3.2%1.5% | 2.7+27.8%1.9% | 2.1+94.8%1.8% | 1.1+27.7%0.8% | 0.8—1.1% | 0—0.0% | |
| Selling, general and administrative | 121+14.3%44.9% | 106+20.8%47.4% | 88+28.9%48.0% | 68+24.2%49.1% | 55+3.9%46.9% | 53+27.7%40.2% | 41+20.6%51.6% | 34—53.2% | |
| Operating income | 23+28.2%8.5% | 18+24.9%8.0% | 14+73.7%7.8% | 8.3−28.7%5.9% | 12−56.8%9.9% | 27+202%20.4% | 8.9r8.7−11.9%11.0% | 10—15.6% | |
| Share of profit of associates | 0—0.0% | −1.0−297%−0.4% | 0.5−48.1%0.3% | 0.9−24.7%0.7% | 1.2+1264%1.1% | 0.1—0.1% | −0.1—−0.1% | — | |
| Other non-operating income (expense) | 0.3—0.1% | −0.2−277%−0.1% | 0.1−90.1%0.1% | 1.0−39.0%0.7% | 1.6−59.0%1.4% | 4.0—3.0% | −0.0—−0.0% | — | |
| Income before tax | 22+34.6%8.1% | 16+12.4%7.2% | 14+60.1%7.9% | 9.0−28.1%6.5% | 13−52.6%10.7% | 26+200%20.1% | 8.8−9.0%11.0% | 9.7—15.0% | |
| Income tax | 6.4+34.2%2.4% | 4.8+14.8%2.1% | 4.1+49.9%2.3% | 2.8−18.0%2.0% | 3.4—2.9% | −5.2−2007%−3.9% | 0.3+67.3%0.3% | 0.2—0.3% | |
| Net income including minority interests | 15+34.8%5.7% | 11+11.4%5.1% | 10+64.6%5.6% | 6.2—4.5% | — | — | — | — | |
| Minority interests' share of net income | 0.4+207%0.2% | 0.1—0.1% | 0—0.0% | 0—0.0% | — | — | — | — | |
| Net income attributable to shareholders | 15+32.6%5.5% | 11+10.0%5.0% | 10+64.6%5.6% | 6.2−31.8%4.5% | 9.1−71.1%7.8% | 32+270%24.0% | 8.5−10.3%10.6% | 9.5—14.7% | |
| Earnings per share, basic | 0.38+31.0%— | 0.29+7.4%— | 0.27+68.8%— | 0.16−30.4%— | 0.23−71.6%— | 0.81+252%— | 0.23−8.0%— | 0.25—— | |
| Earnings per share, diluted | 0.37+32.1%— | 0.28+12.0%— | 0.25+56.3%— | 0.16−27.3%— | 0.22−71.8%— | 0.78+271%— | 0.21−12.5%— | 0.24—— | |
| Shares, weighted average (basic) | 39+0.4%— | 39+1.0%— | 38−0.8%— | 39−2.1%— | 39+1.9%— | 39+2.7%— | 38−0.5%— | 38—— | |
| Shares, weighted average (diluted) | 41+0.0%— | 41+1.1%— | 40+1.4%— | 40−2.1%— | 41+0.4%— | 41+2.0%— | 40+0.2%— | 40—— | |
| Balance sheet | |||||||||
| Cash and cash equivalents | 14−23.0%6.8% | 18+36.6%9.9% | 13−24.1%8.3% | 17−40.5%14.5% | 28−8.3%24.1% | 31+132%27.5% | 13+28.3%16.2% | 10—19.4% | |
| Receivables | 26+2.7%12.8% | 25+35.0%14.1% | 18+20.0%11.9% | 15+19.9%13.1% | 13+3.6%10.9% | 12+7.3%11.0% | 12+30.5%14.0% | 8.8—16.5% | |
| Inventory | 5.0+16.8%2.5% | 4.3−6.7%2.4% | 4.6+29.5%3.0% | 3.6+45.5%3.1% | 2.5+6.4%2.1% | 2.3+69.9%2.1% | 1.4−52.9%1.6% | 2.9—5.4% | |
| Other current assets | 4.1−32.4%2.1% | 6.1+149%3.5% | 2.4−36.4%1.6% | 3.8+123%3.3% | 1.7+14.4%1.5% | 1.5−3.3%1.3% | 1.6+64.1%1.9% | 1.0r0.8—1.8% | |
| Current assets | 48−8.3%24.3% | 53+37.8%29.9% | 38−3.5%24.8% | 40−16.0%34.0% | 47+0.3%40.1% | 47+69.6%41.9% | 28+20.4%33.7% | 23r23—43.0% | |
| Property, plant and equipment | 79+3.3%39.6% | 76+3.7%43.1% | 74+8.6%47.5% | 68r68+7.8%57.9% | 63+14.1%53.3% | 55+0.5%48.9% | 55+79.2%66.3% | 31—57.0% | |
| Right-of-use (leased) assets | 3.6+26.5%1.8% | 2.8−1.4%1.6% | 2.9+314%1.9% | 0.7—0.6% | — | — | — | — | |
| Goodwill | 59+78.7%29.6% | 33+10.8%18.6% | 30—19.2% | 0—0.0% | — | — | — | — | |
| Other intangible assets | 1.3+51.5%0.6% | 0.8+49.6%0.5% | 0.6—0.4% | 0—0.0% | — | — | — | — | |
| Investments in associates | — | — | 0.3−60.8%0.2% | 0.8−14.9%0.7% | 1.0+616%0.8% | 0.1r0.7+931%0.1% | 0.0—0.0% | — | |
| Non-current assets | 151+21.3%75.7% | 124+6.6%70.1% | 117+50.7%75.2% | 77+9.4%66.0% | 71+8.1%59.9% | 65+19.3%58.1% | 55+79.3%66.3% | 31—57.0% | |
| Total assets | 199+12.5%100% | 177+14.3%100% | 155+32.3%100% | 117−0.8%100% | 118+4.8%100% | 113+36.3%100% | 83+53.9%100% | 54r54—100% | |
| Accounts payable | 7.3+37.8%3.7% | 5.3+27.3%3.0% | 4.2+57.7%2.7% | 2.7−18.2%2.3% | 3.2+54.5%2.7% | 2.1−55.4%1.9% | 4.7−20.1%5.7% | 5.9—11.0% | |
| Debt due within a year | 1.1+167%0.5% | 0.4−61.8%0.2% | 1.1—0.7% | 0−100%0.0% | 1.5−19.4%1.3% | 1.8+4.9%1.6% | 1.8—2.1% | 0—0.0% | |
| Current liabilities | 41+10.0%20.6% | 37+16.2%21.1% | 32+70.3%20.7% | 19+5.9%16.1% | 18−22.6%15.1% | 23−11.2%20.4% | 26+32.4%31.4% | 20r17—36.5% | |
| Long-term debt | 11+215%5.7% | 3.6−40.2%2.0% | 6.0—3.9% | 0−100%0.0% | 4.3−25.7%3.7% | 5.8−24.0%5.1% | 7.6—9.2% | 0—0.0% | |
| Lease liabilities (non-current) | 2.4+17.8%1.2% | 2.0−8.1%1.1% | 2.2+997%1.4% | 0.2—0.2% | — | — | — | — | |
| Non-current liabilities | 15+126%7.3% | 6.4−27.4%3.6% | 8.9+716%5.7% | 1.1−79.6%0.9% | 5.3−32.1%4.5% | 7.9−39.5%7.0% | 13+759%15.7% | 1.5—2.8% | |
| Total liabilities | 56+27.1%27.9% | 44+6.8%24.7% | 41+106%26.5% | 20−13.8%17.0% | 23−25.0%19.6% | 31−20.6%27.4% | 39+84.5%47.1% | 21r18—39.3% | |
| Retained earnings | 103+14.7%51.7% | 90+12.8%50.7% | 79+13.8%51.3% | 70−4.8%59.7% | 73+11.7%62.2% | 66+92.4%58.3% | 34+25.8%41.3% | 27r30—50.5% | |
| Shareholders' equity | 142+7.7%71.1% | 131+15.4%74.2% | 114+17.3%73.5% | 97+2.4%83.0% | 95+16.1%80.4% | 82+86.9%72.6% | 44+34.2%52.9% | 33r35—60.7% | |
| Minority interests | 2.0+3.6%1.0% | 1.9—1.1% | 0—0.0% | — | — | — | — | — | |
| Total equity | 144+7.7%72.1% | 133+17.0%75.3% | 114+17.3%73.5% | 97+2.4%83.0% | 95—80.4% | — | — | — | |
| Total liabilities and equity | 199+12.5%100% | 177+14.3%100% | 155+32.3%100% | 117−0.8%100% | 118+4.8%100% | 113+36.3%100% | 83+53.9%100% | 54r54—100% | |
| Shares outstanding | 38−2.8%— | 39+1.6%— | 39+1.2%— | 38−4.0%— | 40+1.2%— | 39+3.2%— | 38+1.2%— | 38—— | |
| Cash-flow statement | |||||||||
| Depreciation and amortization | 29+12.8%10.6% | 25+16.0%11.3% | 22+39.9%11.9% | 16—11.3% | — | — | — | — | |
| Share-based compensation | 9.1+45.3%3.4% | 6.3+7.5%2.8% | 5.8+12.4%3.2% | 5.2+1.0%3.7% | 5.2+5.5%4.4% | 4.9+25.6%3.7% | 3.9+43.8%4.8% | 2.7—4.2% | |
| Cash from operating activities | 52+32.8%19.2% | 39−13.5%17.4% | 45+62.9%24.7% | 28+23.4%20.0% | 22−35.9%19.2% | 35+83.9%26.7% | 19−14.7%23.8% | 22—34.7% | |
| Capital expenditure | −40—−14.8% | −38—−16.8% | −26—−14.3% | −23—−16.5% | −20—−16.9% | −13—−9.9% | −13—−16.7% | −6.1—−9.5% | |
| Acquisitions, net of cash acquired | −26—−9.7% | −3.0—−1.3% | −29—−15.6% | 0—0.0% | — | — | — | — | |
| Cash from investing activities | −50—−18.6% | −31—−13.7% | −52—−28.5% | −24—−17.3% | −20—−16.9% | −8.4—−6.4% | −13—−16.0% | −5.3—−8.2% | |
| Debt issued | — | — | — | — | — | — | 5.0—6.2% | 0—0.0% | |
| Debt repaid | — | — | — | — | — | — | −0.4—−0.5% | 0—0.0% | |
| Shares bought back | −13—−4.9% | 0—0.0% | 0—0.0% | −9.6—−6.9% | 0r−1.4—0.0% | 0—0.0% | −1.5—−1.9% | −1.6—−2.5% | |
| Cash from financing activities | −5.8—−2.1% | −3.7−231%−1.6% | 2.8—1.5% | −15—−11.0% | −5.3—−4.5% | −9.1—−6.9% | −3.3—−4.2% | −12—−18.2% | |
| Change in cash | −4.0−186%−1.5% | 4.7—2.1% | −4.1—−2.2% | −11—−8.3% | −2.6−115%−2.2% | 18+499%13.4% | 2.9−44.6%3.7% | 5.3—8.2% | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q3 FY2026to Sep 30, 2026 | Q2 FY2026to Jun 30, 2026 | Q1 FY2026to Mar 31, 2026 | Q4 FY2025to Dec 31, 2025 | Q3 FY2025to Sep 30, 2025 | Q2 FY2025to Jun 30, 2025 | Q1 FY2025to Mar 31, 2025 | Q4 FY2024to Dec 31, 2024 | Q3 FY2024to Sep 30, 2024 | Q2 FY2024to Jun 30, 2024 | Q1 FY2024to Mar 31, 2024 | Q4 FY2023to Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 310+21.8%100% | 81+12.2%100% | 78+23.9%100% | 75+27.5%100% | 76*+25.5%100% | 72+24.0%100% | 63+14.7%100% | 59+16.9%100% | 61*+19.6%100% | 58—100% | 55—100% | 51—100% | 51*—100% | |
| Cost of revenue | 132+23.2%42.6% | 34+12.8%42.7% | 33+25.5%42.3% | 33+26.1%43.2% | 32*+30.6%42.1% | 31+29.3%42.5% | 26+19.3%41.7% | 26+24.3%43.7% | 25*+31.8%40.5% | 24—40.7% | 22—40.2% | 21—41.1% | 19*—36.7% | |
| Gross profit | 178+20.8%57.4% | 46+11.7%57.3% | 45+22.6%57.7% | 43+28.7%56.8% | 44*+22.0%57.9% | 41+20.3%57.5% | 37+11.7%58.3% | 33+11.7%56.3% | 36*+12.5%59.5% | 34—59.3% | 33—59.8% | 30—58.9% | 32*—63.3% | |
| Research and development | 2.2−32.3%0.7% | 0.5−35.4%0.6% | 0.5−40.5%0.6% | 0.6−27.4%0.8% | 0.6*−25.5%0.8% | 0.8+2.4%1.1% | 0.8+11.7%1.3% | 0.8+6.3%1.3% | 0.8*+23.3%1.3% | 0.8—1.3% | 0.8—1.4% | 0.8—1.5% | 0.7*—1.3% | |
| Selling, general and administrative | 140+19.0%45.0% | 36+11.2%44.0% | 37+28.9%47.5% | 35+22.4%46.1% | 32*+14.2%42.3% | 32+19.7%44.4% | 29+8.7%45.7% | 28+14.6%48.1% | 28*+18.0%46.5% | 27—46.0% | 27—48.2% | 25—49.0% | 24*—47.1% | |
| Operating income | 24+14.6%7.8% | 7.0+23.4%8.6% | 4.5−12.4%5.7% | 4.3+11.8%5.7% | 8.4*+29.7%11.0% | 5.6+0.2%7.8% | 5.1+40.9%8.1% | 3.8+74.3%6.5% | 6.5*+22.0%10.6% | 5.6—9.7% | 3.6—6.6% | 2.2—4.4% | 5.3*—10.4% | |
| Interest expense and finance costs | — | 0.2−65.1%0.2% | 0.2+87.9%0.3% | 0.3+70.4%0.4% | — | 0.5—0.7% | 0.1—0.2% | 0.2—0.3% | — | — | — | — | — | |
| Share of profit of associates | — | — | — | — | 0*—0.0% | 0−100%0.0% | 0—0.0% | 0−100%0.0% | 0*−100%0.0% | 0.1—0.2% | −1.1—−2.0% | 0.1—0.1% | 0.0*—0.1% | |
| Other non-operating income (expense) | 0.2−20.4%0.1% | 0.1+34.1%0.1% | 0.1−6.9%0.1% | 0.0−53.3%0.0% | 0.1*−30.7%0.1% | 0.0−84.1%0.1% | 0.1—0.1% | 0.1+188%0.1% | 0.1*—0.1% | 0.3—0.5% | −0.6—−1.0% | 0.0—0.1% | −0.0*—−0.1% | |
| Income before tax | 23+13.8%7.4% | 6.8+32.1%8.4% | 4.1−18.4%5.2% | 4.0+9.0%5.3% | 8.0*+27.0%10.5% | 5.1−6.6%7.1% | 5.0+121%7.9% | 3.7+72.7%6.2% | 6.3*+24.2%10.4% | 5.5—9.5% | 2.2—4.1% | 2.1—4.2% | 5.1*—10.0% | |
| Income tax | 6.7+9.7%2.1% | 2.0+33.4%2.5% | 1.2−32.8%1.5% | 1.3+34.2%1.7% | 2.2*+16.5%2.9% | 1.5−3.7%2.1% | 1.7+123%2.7% | 1.0+83.8%1.6% | 1.9*+17.6%3.1% | 1.6—2.7% | 0.8—1.4% | 0.5—1.0% | 1.6*—3.2% | |
| Net income including minority interests | 16+15.6%5.2% | 4.7+31.6%5.9% | 2.9−10.8%3.7% | 2.7+0.1%3.6% | 5.8*+31.5%7.6% | 3.6−7.8%5.0% | 3.3+120%5.2% | 2.7+69.1%4.6% | 4.4*+27.2%7.3% | 3.9—6.7% | 1.5—2.7% | 1.6—3.2% | 3.5*—6.9% | |
| Minority interests' share of net income | 0.5+45.6%0.2% | 0.1+13.8%0.1% | 0.1+46.2%0.2% | 0.1+54.1%0.2% | 0.2*+63.9%0.2% | 0.1+222%0.1% | 0.1+933%0.1% | 0.1—0.1% | 0.1*—0.2% | 0.0—0.0% | 0.0—0.0% | 0—0.0% | 0*—0.0% | |
| Net income attributable to shareholders | 16+14.8%5.0% | 4.6+32.0%5.7% | 2.8−12.4%3.5% | 2.6−1.6%3.4% | 5.6*+30.7%7.4% | 3.5−9.4%4.9% | 3.2+115%5.0% | 2.6+63.8%4.4% | 4.3*+24.1%7.1% | 3.9—6.7% | 1.5—2.7% | 1.6—3.2% | 3.5*—6.9% | |
| Earnings per share, basic | — | 0.12+33.3%— | 0.07−12.5%— | 0.070.0%— | — | 0.09−10.0%— | 0.08+100%— | 0.07+75.0%— | — | 0.10—— | 0.04—— | 0.04—— | — | |
| Earnings per share, diluted | — | 0.11+22.2%— | 0.07−12.5%— | 0.060.0%— | — | 0.09−10.0%— | 0.08+100%— | 0.06+50.0%— | — | 0.10—— | 0.04—— | 0.04—— | — | |
| Shares, weighted average (basic) | 38−1.4%— | 38−1.4%— | 38−3.2%— | 38−2.5%— | — | 39−0.6%— | 40+1.8%— | 39+1.8%— | — | 39—— | 39—— | 39—— | — | |
| Shares, weighted average (diluted) | 41+1.7%— | 41+1.7%— | 41+0.1%— | 40−2.7%— | — | 40−0.7%— | 41+1.3%— | 42+2.6%— | — | 41—— | 41—— | 41—— | — | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 9.7—4.7% | 9.7−13.0%4.7% | 11−46.6%5.2% | 9.8−3.9%4.9% | 14−23.0%6.8% | 11−2.0%5.5% | 20+127%10.8% | 10+39.0%5.7% | 18+36.6%9.9% | 11—6.7% | 8.8—5.4% | 7.3—4.7% | 13—8.3% | |
| Receivables | 35—16.8% | 35+27.3%16.8% | 32+21.4%15.8% | 31+16.4%15.8% | 26+2.7%12.8% | 27+1.3%13.5% | 27−1.9%14.4% | 27+9.4%15.0% | 25+35.0%14.1% | 27—16.0% | 27—16.5% | 24—15.8% | 18—11.9% | |
| Inventory | 4.6—2.2% | 4.6−13.6%2.2% | 5.3+21.8%2.6% | 5.2+14.9%2.6% | 5.0+16.8%2.5% | 5.3+22.2%2.6% | 4.3−2.3%2.3% | 4.5+3.7%2.5% | 4.3−6.7%2.4% | 4.3—2.5% | 4.4—2.7% | 4.3—2.8% | 4.6—3.0% | |
| Other current assets | 10—4.9% | 10+139%4.9% | 5.8+31.5%2.8% | 3.7−51.9%1.9% | 4.1−32.4%2.1% | 4.3−14.5%2.1% | 4.4+3.9%2.4% | 7.7+209%4.3% | 6.1+149%3.5% | 5.0—2.9% | 4.2—2.6% | 2.5—1.6% | 2.4—1.6% | |
| Current assets | 59—28.6% | 59+18.6%28.6% | 54−2.4%26.4% | 50+1.4%25.2% | 48−8.3%24.3% | 50+4.8%24.7% | 55+22.9%30.0% | 49+27.2%27.6% | 53+37.8%29.9% | 48—28.1% | 45—27.4% | 39—24.9% | 38—24.8% | |
| Property, plant and equipment | 76—36.4% | 76−6.1%36.4% | 77−3.2%37.8% | 76−6.2%38.5% | 79+3.3%39.6% | 81+8.2%39.8% | 80+6.7%43.2% | 81+10.3%45.5% | 76+3.7%43.1% | 74—43.9% | 75—45.6% | 74—47.5% | 74—47.5% | |
| Right-of-use (leased) assets | 4.2—2.0% | 4.2+18.2%2.0% | 4.5+71.7%2.2% | 3.3+14.7%1.7% | 3.6+26.5%1.8% | 3.6+30.1%1.8% | 2.6−8.8%1.4% | 2.9+5.3%1.6% | 2.8−1.4%1.6% | 2.8—1.6% | 2.9—1.8% | 2.7—1.8% | 2.9—1.9% | |
| Goodwill | 59—28.4% | 59+0.8%28.4% | 59+78.7%28.9% | 59+78.7%29.9% | 59+78.7%29.6% | 58+77.2%28.9% | 330.0%17.9% | 33+10.8%18.5% | 33+10.8%18.6% | 33—19.5% | 33—20.1% | 30—19.2% | 30—19.2% | |
| Other intangible assets | 1.1—0.5% | 1.1−18.8%0.5% | 1.2+47.9%0.6% | 1.2+49.6%0.6% | 1.3+51.5%0.6% | 1.3+53.2%0.7% | 0.8−14.1%0.4% | 0.8+52.8%0.5% | 0.8+49.6%0.5% | 0.9—0.5% | 0.9—0.6% | 0.5—0.3% | 0.6—0.4% | |
| Investments in associates | — | — | — | — | — | — | — | — | — | — | 0.4—0.3% | 0.3—0.2% | 0.3—0.2% | |
| Non-current assets | 148—71.4% | 148−2.6%71.4% | 150+16.2%73.6% | 148+14.4%74.8% | 151+21.3%75.7% | 152+25.1%75.3% | 129+8.7%70.0% | 129+10.9%72.4% | 124+6.6%70.1% | 122—71.9% | 119—72.6% | 116—75.1% | 117—75.2% | |
| Total assets | 208—100% | 208+2.6%100% | 204+10.6%100% | 197+10.8%100% | 199+12.5%100% | 202+19.4%100% | 185+12.6%100% | 178+15.0%100% | 177+14.3%100% | 170—100% | 164—100% | 155—100% | 155—100% | |
| Accounts payable | 11—5.1% | 11+22.6%5.1% | 11+33.1%5.4% | 8.6+7.9%4.3% | 7.3+37.8%3.7% | 8.7+44.3%4.3% | 8.3+30.3%4.5% | 7.9+37.0%4.5% | 5.3+27.3%3.0% | 6.0—3.5% | 6.3—3.9% | 5.8—3.7% | 4.2—2.7% | |
| Debt due within a year | 0.5—0.2% | 0.5−67.1%0.2% | 0.7−12.6%0.4% | 0.9+123%0.4% | 1.1+167%0.5% | 1.6+91.4%0.8% | 0.8+6.2%0.4% | 0.4−34.6%0.2% | 0.4−61.8%0.2% | 0.8—0.5% | 0.8—0.5% | 0.6—0.4% | 1.1—0.7% | |
| Current liabilities | 47—22.8% | 47+7.1%22.8% | 48+28.5%23.5% | 41+14.7%20.6% | 41+10.0%20.6% | 44+21.3%21.8% | 37+18.4%20.2% | 35+17.8%19.9% | 37+16.2%21.1% | 36—21.5% | 31—19.2% | 30—19.4% | 32—20.7% | |
| Long-term debt | 4.5—2.2% | 4.5−77.0%2.2% | 6.4+84.0%3.1% | 8.3+136%4.2% | 11+215%5.7% | 20+437%9.7% | 3.5−60.2%1.9% | 3.5−40.2%2.0% | 3.6−40.2%2.0% | 3.7—2.2% | 8.7—5.3% | 5.9—3.8% | 6.0—3.9% | |
| Lease liabilities (non-current) | 2.8—1.4% | 2.8+17.6%1.4% | 3.1+82.5%1.5% | 2.0+6.7%1.0% | 2.4+17.8%1.2% | 2.4+21.4%1.2% | 1.7−19.5%0.9% | 1.9−6.6%1.1% | 2.0−8.1%1.1% | 2.0—1.2% | 2.1—1.3% | 2.0—1.3% | 2.2—1.4% | |
| Non-current liabilities | 8.3—4.0% | 8.3−63.3%4.0% | 10+81.6%5.1% | 11+85.8%5.5% | 15+126%7.3% | 23+261%11.2% | 5.7−49.4%3.1% | 5.8−31.1%3.3% | 6.4−27.4%3.6% | 6.3—3.7% | 11—6.9% | 8.5—5.5% | 8.9—5.7% | |
| Total liabilities | 56—26.8% | 56−16.8%26.8% | 58+35.6%28.5% | 52+24.8%26.1% | 56+27.1%27.9% | 67+56.5%33.0% | 43+0.5%23.3% | 41+7.1%23.2% | 44+6.8%24.7% | 43—25.2% | 43—26.1% | 39—24.9% | 41—26.5% | |
| Retained earnings | 113—54.4% | 113+16.1%54.4% | 108+15.3%53.0% | 105+16.2%53.4% | 103+14.7%51.7% | 97+13.9%48.1% | 94+15.0%50.8% | 91+13.2%51.0% | 90+12.8%50.7% | 85—50.4% | 82—49.8% | 80—51.7% | 79—51.3% | |
| Shareholders' equity | 150—72.3% | 150+12.3%72.3% | 144+3.1%70.5% | 144+6.8%72.9% | 142+7.7%71.1% | 134+6.9%66.0% | 140+17.1%75.7% | 135+15.9%75.7% | 131+15.4%74.2% | 125—73.7% | 119—72.8% | 116—75.1% | 114—73.5% | |
| Minority interests | 1.9—0.9% | 1.9+0.6%0.9% | 1.9+2.3%0.9% | 1.9−3.0%1.0% | 2.0+3.6%1.0% | 1.9+2.8%0.9% | 1.9+4.6%1.0% | 2.0—1.1% | 1.9—1.1% | 1.8—1.1% | 1.8—1.1% | — | 0—0.0% | |
| Total equity | 152—73.2% | 152+12.2%73.2% | 146+3.1%71.5% | 146+6.6%73.9% | 144+7.7%72.1% | 135+6.9%67.0% | 142+16.9%76.7% | 137+17.6%76.8% | 133+17.0%75.3% | 127—74.8% | 121—73.9% | 116—75.1% | 114—73.5% | |
| Total liabilities and equity | 208—100% | 208+2.6%100% | 204+10.6%100% | 197+10.8%100% | 199+12.5%100% | 202+19.4%100% | 185+12.6%100% | 178+15.0%100% | 177+14.3%100% | 170—100% | 164—100% | 155—100% | 155—100% | |
| Shares outstanding | 38—— | 38+0.1%— | 38−3.8%— | 39−2.5%— | 38−2.8%— | 38−2.3%— | 40+2.0%— | 40+1.8%— | 39+1.6%— | 39—— | 39—— | 39—— | 39—— | |
| Cash-flow statement | ||||||||||||||
| Depreciation and amortization | 16+16.3%5.1% | 0.4−1.3%0.5% | 0.4+9.9%0.5% | 7.6+15.2%10.1% | 7.6*+18.9%9.9% | 0.4+14.1%0.6% | 0.4−6.4%0.6% | 6.6+5.2%11.2% | 6.4*+7.6%10.5% | 0.3—0.6% | 0.4—0.7% | 6.3—12.4% | 5.9*—11.7% | |
| Share-based compensation | 9.3+10.8%3.0% | 2.5+13.6%3.1% | 2.0−13.2%2.6% | 2.5+6.1%3.3% | 2.3*+51.2%3.0% | 2.2+27.3%3.0% | 2.3+44.5%3.7% | 2.3+61.4%3.9% | 1.5*−0.8%2.5% | 1.7—3.0% | 1.6—2.9% | 1.4—2.8% | 1.5*—3.0% | |
| Cash from operating activities | 54+11.2%17.4% | 11*−37.5%14.2% | 16*+29.8%20.4% | 8.1+183%10.7% | 18*+23.0%24.2% | 18*+44.1%25.5% | 12*+20.3%19.4% | 2.9+143%4.8% | 15*+12.8%24.7% | 13*—22.0% | 10*—18.5% | 1.2—2.3% | 13*—26.2% | |
| Capital expenditure | −33—−10.5% | −8.6*—−10.7% | −8.5*—−10.8% | −6.7—−8.9% | −8.7*—−11.5% | −7.6*—−10.6% | −8.1*—−12.9% | −15—−26.2% | −12*—−19.5% | −11*—−19.0% | −8.9*—−16.3% | −6.0—−11.9% | −7.9*—−15.6% | |
| Acquisitions, net of cash acquired | — | — | — | — | 0*—0.0% | −26*—−36.6% | — | — | 0*—0.0% | 0*—0.0% | — | — | −0.0*—−0.0% | |
| Cash from investing activities | −28—−9.1% | −7.5*—−9.2% | −7.8*—−10.0% | −5.5—−7.3% | −7.6*—−10.0% | −32*—−44.9% | −1.7*—−2.7% | −8.5—−14.4% | −9.2*—−15.2% | −5.0*—−8.6% | −11*—−20.3% | −5.4—−10.6% | −7.5*—−14.8% | |
| Shares bought back | −7.7—−2.5% | −1.0*—−1.2% | −5.3*—−6.8% | −1.4—−1.9% | 0*—0.0% | −12*—−16.1% | −1.7*—−2.6% | 0—0.0% | 0*—0.0% | 0*—0.0% | — | — | 0*—0.0% | |
| Cash from financing activities | −27−979%−8.7% | −5.0*−200%−6.2% | −7.1*—−9.2% | −6.3—−8.4% | −8.5*−2192%−11.1% | 5.0*—7.0% | −0.7*−127%−1.1% | −1.7—−2.9% | 0.4*—0.7% | −5.2*—−9.0% | 2.5*—4.5% | −1.3—−2.6% | −3.0*—−6.0% | |
| Change in cash | −1.4—−0.5% | −1.0*—−1.2% | 0.9*−90.7%1.2% | −3.7—−5.0% | 2.4*−61.6%3.1% | −8.9*−450%−12.4% | 9.9*+558%15.6% | −7.4—−12.5% | 6.2*+124%10.2% | 2.5*—4.4% | 1.5*—2.7% | −5.5—−10.9% | 2.8*—5.4% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
What Viemed Healthcare, Inc. sells: revenue by product line, fiscal 2025#
As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.
Products and services
- Equipment and supply sales$50 M19%+63%
- Service revenues(total)$25 M9.2%+24%
Source: SEC annual report (XBRL data) · as of Dec 31, 2025
Executive pay at Viemed Healthcare, Inc.#
From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.
| Fiscal year | CEO total pay | Actually paid | Other executives, average | $100 invested |
|---|---|---|---|---|
| 2025Casey Hoyt | $2.6 M | $2.3 M | $2.0 M | $142 (peers $100) |
| 2024Casey Hoyt | $2.6 M | $2.5 M | $1.5 M | $154 (peers $85) |
| 2023Casey Hoyt | $2.5 M | $2.5 M | $1.4 M | $150 (peers $84) |
| 2022Casey Hoyt | $1.9 M | $2.8 M | $1.1 M | $145 (peers $80) |
Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025
Events at Viemed Healthcare, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.
Directors and officers 4 · Material agreement 3 · New debt 1 · Shareholder vote 3 · Results announced 10
| Filed | What happened | Filing |
|---|---|---|
| Results announced | 8-K | |
| Results announced | 8-K | |
| Directors and officersShareholder vote | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Material agreement | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Material agreement | 8-K | |
| Directors and officersShareholder vote | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Directors and officersShareholder vote | 8-K | |
| Material agreementNew debt | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 4, 2026
Acquisitions and funding#
2 acquisitions, $59 M paid where reported · 1 private funding rounds before listing
Businesses it acquired
| Acquired | Acquisition date | Completion | Price | Stake | Source |
|---|---|---|---|---|---|
| Lehan Drugs, Inc | 2025 | — | $29 M | 100% | Annual report |
| Home Medical Products Inc | 2023 | — | $29 M | 100% | Annual report |
Private share sales · funding history
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jan 2018 | $3 M | No. 1 | $2 to $10 million | 5 | options | SEC |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
Lobbying by Viemed Healthcare, Inc.#
$0 spent on lobbying the US Congress and federal agencies in 2022.
Lobbying firms hired in 2022
Forbes-Tate
| Year | Spending | Own lobbyists | Reports |
|---|---|---|---|
| 2022 | $0 | — | 3 |
| 2021 | $0 | — | 4 |
| 2020 | $130 K | — | 2 |
Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “VieMed Healthcare, Inc.”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero
How Viemed Healthcare, Inc. compares in Medical Equipment
- Market cap$367 M · higher than 86% of 8
- Revenue$270 M · higher than 83% of 19
- Net margin5.0% · higher than 75% of 17
- Revenue growth20.5% · higher than 75% of 13
- Price / sales1.2× · lower than 50% of 7
- Price / book2.6× · lower than 50% of 7
- FCF yield3.3% · highest of 7
- 🇺🇸 Electromed, Inc.$341 M
- 🇺🇸 Avita Medical, Inc.$525 M
- 🇨🇦 Profound Medical Corp.$240 M
- 🇺🇸 Streamex Corp.$52 M
- 🇺🇸 TELA Bio, Inc.$52 M
- 🇺🇸 IRIDEX Corporation$12 M
Peer comparison · Medical Equipment
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Viemed Healthcare, Inc.🇺🇸 | $367 M | 23.5× | 5.0% | +20.5% |
| Avita Medical, Inc.🇺🇸 | $525 M | — | -42.6% | +11.5% |
| Electromed, Inc.🇺🇸 | $341 M | 28.6× | 15.8% | +15.3% |
| Profound Medical Corp.🇨🇦 | $240 M | — | -137.4% | +50.8% |
| Streamex Corp.🇺🇸 | $52 M | — | — | +100.0% |
| TELA Bio, Inc.🇺🇸 | $52 M | — | -53.6% | +15.8% |
| IRIDEX Corporation🇺🇸 | $12 M | — | -6.9% | +8.2% |
| Beyond Air, Inc.🇺🇸 | $4 M | — | -407.6% | +107.6% |
| Varian Medical Systems🇺🇸 | $16.3 B | — | 8.5% | -1.8% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Electromed, Inc.$341 M
- Avita Medical, Inc.$525 M
- Profound Medical Corp.$240 M
- Streamex Corp.$52 M
- TELA Bio, Inc.$52 M
- IRIDEX Corporation$12 M
Sources and freshness
- Market cap:
- Oct 15, 2026
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Viemed Healthcare, Inc.? Verify and update this profile — free
Show Viemed Healthcare, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.